Viewing data from:

MIDAZOLAM HYDROCHLORIDE

ANDA

MIDAZOLAM HYDROCHLORIDE | A075637 | BAXTER HEALTHCARE CORP

2 strengths0 unique patents0 unique exclusivities

API Supply Chain1 active DMF

1 active API supplier hold Drug Master Files for this ingredient. Limited supplier base — potential supply chain risk.

CAMBREX PROFARMACO MILANO SRLMIDAZOLAM HYDROCHLORIDE

DMF 399912024

Source: FDA Drug Master Files (fda.gov). Type II API DMFs matched by ingredient.

Approval Letters

1 letter from Drugs@FDA

Date	Submission	Document
Oct 31, 2000	ORIG -1	View Letter (PDF)

Source: Drugs@FDA application documents.

Products (2)

Sort:

#001 — EQ 1MG BASE/ML

0 patents0 exclusivities▴

INJECTABLE;INJECTION | Approved: Oct 31, 2000

No patent or exclusivity listings for this strength.

#002 — EQ 5MG BASE/ML

0 patents0 exclusivities▾

INJECTABLE;INJECTION | Approved: Oct 31, 2000